This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by de Haro, L Articles by Choumet, V Search for Related Content PubMed PubMed Citation Articles by de Haro, L Articles by Choumet, V Social Bookmarking                         What's this?

Unusual neurotoxic envenomations byVipera aspis aspis snakes in France

Centre Anti-Poisons, Hôpital Salvator, 249, Bd Sainte Marguerite, 13274 Marseille Cedex 9, France

A Robbe-Vincent

B Saliou

Unité des Venins, Institut Pasteur, 25, rue du Dr Roux, 75724 Paris Cedex 15, France

M Valli

Centre Anti-Poisons, Hôpital Salvator, 249, Bd Sainte Marguerite, 13274 Marseille Cedex 9, France

C Bon

Unité des Venins, Institut Pasteur, 25, rue du Dr Roux, 75724 Paris Cedex 15, France

V Choumet

Unité des Venins, Institut Pasteur, 25, rue du Dr Roux, 75724 Paris Cedex 15, France; vchoumel{at}pasteur.fr

Vipera aspis aspis (V.a.a.) is the most dangerous poisonous snake in South-Eastern France. The clinical symptoms observed after V.a.a. envenomations involve mostly local signs (pain, edema) associated in the more severe cases with systemic symptoms (gastro-intestinal and cardiovascular manifestations). Since 1992, several unusual cases of moderate and severe `neurotoxic’ envenomations by V.a.a. snakes have been reported in a very localized area in South-Eastern France. Most of the human patients mainly suffered neurological signs owing to cephalic muscle paralysis. Drowsiness and dyspnea were observed for the most severe cases. Envenomed animals suffered respiratory distress and paralysis. The local signs were never as severe as observed after envenomations by vipers in other French regions. Human patients with moderate or severe clinical features received two intravenous injections of Viperfav² antivenom, the first dose inducing the decrease of the neurological signs and the second reducing significantly the edema. Neurotoxic components immunologically cross-reacting with toxins from V. ammodytes ammodytes venom from Eastern Europe were detected in the blood of all patients suffering neurological symptoms after a V.a.a. bite. The protective efficacy of various antivenoms was evaluated in mice. The existence of geographical variations in the composition of V.a.a. venom emphasizes on the use of polyvalent antivenom in the treatment of viper envenomations in France. Human & Experimental Toxicology (2002) 21, 137 – 145.

Key Words: envenomations • neurotoxin • phospholipase A2 • sero-therapy • snakebite • Viperaaspisaspis

Human & Experimental Toxicology, Vol. 21, No. 3, 137-145 (2002)
DOI: 10.1191/0960327102ht226oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. Malina, L. Krecsak, and D.A. Warrell Neurotoxicity and hypertension following European adder (Vipera berus berus) bites in Hungary: case report and review QJM, October 1, 2008; 101(10): 801 - 806. [Full Text] [PDF]